We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

William H. Kitchens Arnall Golden Gregory LLP

Results 1 to 5 of 34



House holds hearing on FDA’s authority over compounding pharmacies *

USA - April 30 2013
In light of the 2012 fungal meningitis outbreak, regulation of pharmacy drug compounding has received significant attention. On April 16, 2013 the…

Co-authors: Emalee G. Murphy.


FDA issues guidance on medical device product codes *

USA - April 17 2013
The Food and Drug Administration (FDA) announced on Thursday, April 11, 2013, the availability of a guidance document entitled "Medical Device…


Despite growing momentum repeal of medical device tax faces significant hurdles *

USA - April 3 2013
On March 21, 2013, the United States Senate approved an amendment by a vote of 79 to 20 to repeal the 2.3 percent medical device excise tax. The tax…


What’s happening with Food Safety Modernization Act rules *

USA - March 7 2013
While the industry waits for the new rules under the Food Safety Modernization Act (FSMA), here's what I see the FDA is doing regarding these new…


Am I my competitor’s keeper? Alabama’s highest court holds brandname prescription drug manufacturer liable for claims on a generic drug used by the plaintiff *

USA - February 5 2013
The Supreme Court of Alabama recently held that "[u]nder Alabama law, a brand-name drug company may be held liable for fraud or misrepresentation (by…

Co-authors: W. Jerad Rissler.


Next »